The Bayer Roundup lawsuit is one of the largest mass tort cases in American history, with Bayer paying out more than $10 billion to settle tens of thousands of cancer claims tied to its Roundup weed killer. If you or someone in your family used Roundup and later developed cancer, you may still be able to file a claim in 2026.
The lawsuits center on glyphosate, the active ingredient in Roundup. Plaintiffs argue Bayer and its predecessor Monsanto knew about cancer risks for years and said nothing. That silence may be worth a significant legal claim.
This article breaks down exactly who qualifies, what settlements look like, where the litigation stands right now in 2026, and how to get your claim started before deadlines pass.
What Is the Bayer Roundup Lawsuit in 2026?
The Bayer Roundup lawsuit is a mass tort legal action alleging that long-term exposure to Roundup weed killer causes cancer, particularly non-Hodgkin lymphoma.
The litigation began gaining serious momentum after Bayer acquired Monsanto in 2018. Monsanto had been selling Roundup since 1974. The International Agency for Research on Cancer (IARC) classified glyphosate as “probably carcinogenic to humans” in 2015. That single classification triggered tens of thousands of lawsuits.
Bayer inherited those lawsuits along with the Monsanto brand. By 2020, the company had agreed to pay up to $10.9 billion to resolve the majority of claims. But thousands of cases remain active heading into 2026.
| Key Facts | Details |
|---|---|
| Product | Roundup weed killer (glyphosate) |
| Manufacturer | Monsanto (acquired by Bayer AG in 2018) |
| Primary Cancer Claim | Non-Hodgkin lymphoma |
| IARC Classification | Probably carcinogenic (Group 2A, 2015) |
| Total Settlement Value | Over $10.9 billion announced in 2020 |
| MDL Case Number | MDL 2741, Northern District of California |
| Active Claims in 2026 | Estimated tens of thousands still pending |
Bayer has not admitted wrongdoing. The company continues to defend Roundup’s safety in ongoing litigation while simultaneously settling large numbers of claims.
Roundup Lawsuit Settlement Amounts: What Is Bayer Paying?
Roundup lawsuit settlement amounts vary widely, ranging from roughly $5,000 to over $250,000 per claimant, depending on the severity of the cancer diagnosis, age, exposure duration, and other medical factors.
The most serious cases involving advanced cancer diagnoses or deaths have settled for significantly higher amounts. Some individual jury verdicts have reached into the hundreds of millions before being reduced on appeal.
Bayer’s settlement program uses a tiered compensation structure. Claimants are typically placed into categories based on their cancer stage and diagnosis timeline.
| Settlement Tier | Cancer Severity | Estimated Range |
|---|---|---|
| Tier 1 | Aggressive or advanced cancer, long exposure | $100,000 to $250,000+ |
| Tier 2 | Moderate cancer diagnosis, confirmed exposure | $40,000 to $100,000 |
| Tier 3 | Early-stage cancer, shorter exposure history | $5,000 to $40,000 |
| Wrongful Death | Deceased claimants with qualifying diagnosis | Varies, often higher |
These ranges are estimates based on reported settlement patterns. Your specific payout depends on case facts and how your claim is evaluated by the settlement administrator.
Roundup Lawsuit Who Qualifies: Are You Eligible?
You may qualify for the Roundup lawsuit if you used Roundup or other glyphosate-based herbicides and were later diagnosed with a qualifying cancer, most commonly non-Hodgkin lymphoma.
Eligibility is not automatic. Several factors are weighed when determining whether your claim meets the threshold to participate in settlement negotiations or proceed to trial.
Here are the core eligibility requirements:
- Roundup exposure: You used Roundup personally, not just lived near someone who did
- Duration of exposure: Most successful claims involve at least two years of regular use, though shorter exposure histories have qualified in some cases
- Cancer diagnosis: You must have a confirmed diagnosis of non-Hodgkin lymphoma or a related blood cancer
- Timing: Your diagnosis must have occurred after a reasonable period of exposure
Other blood cancer types have been included in certain claims, including B-cell lymphoma, T-cell lymphoma, and mantle cell lymphoma. Your oncologist’s records are a critical piece of documentation.
Key Takeaway: Qualifying for the Roundup lawsuit requires documented exposure and a confirmed cancer diagnosis, but the bar for “enough exposure” is lower than many people assume.
Roundup Lawsuit Payout Per Person: Breaking Down Individual Claims
The average Roundup lawsuit payout per person is estimated at between $50,000 and $160,000, based on publicly reported settlement patterns across resolved claims.
That average is pulled up by high-value cases involving prolonged occupational exposure and severe cancer diagnoses. It is pulled down by early-stage cases and those with limited documentation.
Several factors determine where your claim falls in the payout range:
- Type of cancer and stage at diagnosis: Stage 3 or Stage 4 non-Hodgkin lymphoma claims receive significantly higher compensation
- Age at diagnosis: Younger claimants with longer expected life impact typically receive higher amounts
- Duration and frequency of Roundup use: Occupational users (landscapers, farmers, groundskeepers) often see stronger claims than occasional home users
- Medical expenses: Documented treatment costs strengthen your claim’s value
- Lost wages: If cancer caused you to stop working, that economic loss factors into your payout
Think of it like a home insurance claim. The bigger the documented damage and the clearer the cause, the more the adjuster pays out. Roundup claims work similarly.
Roundup Non-Hodgkin Lymphoma Cancer Link: The Science Behind the Lawsuit
The Roundup lawsuit exists because of a direct scientific link between glyphosate exposure and non-Hodgkin lymphoma, a cancer of the lymphatic system.
In 2015, the IARC reviewed dozens of studies and classified glyphosate as a “probable human carcinogen.” That finding directly contradicts the EPA’s continued position that glyphosate is “not likely to be carcinogenic” at typical usage levels. That conflict between two major agencies is at the heart of every Roundup trial.
The landmark trial that started the avalanche was Johnson v. Monsanto in 2018. Dewayne Johnson, a school groundskeeper who regularly sprayed Roundup, was diagnosed with non-Hodgkin lymphoma. The jury awarded him $289 million initially, later reduced to $78 million on appeal. It was the first successful Roundup trial and proved the case could be won.
| Cancer Type | Linked to Roundup Claims |
|---|---|
| Diffuse large B-cell lymphoma | Yes, most common claim type |
| Follicular lymphoma | Yes |
| Mantle cell lymphoma | Yes |
| T-cell lymphoma | Yes, some subtypes |
| Chronic lymphocytic leukemia | Included in some claims |
Non-Hodgkin lymphoma is a broad category. If you were diagnosed with any lymphoma after Roundup use, it is worth investigating whether your specific subtype qualifies.
Bayer Roundup Settlement 2026 Update: Where Things Stand Now
In 2026, Bayer continues to work through settlement payments on previously resolved claims while facing new lawsuits from people who either missed earlier settlement windows or received recent diagnoses.
Bayer’s original 2020 settlement agreement resolved the bulk of existing claims. But the company set aside an additional $2 billion to handle future claims filed through a separate resolution framework. That pool of money is available to qualifying claimants who file in 2026.
The company has not closed the door on future settlements. In fact, Bayer’s legal strategy has shifted toward resolving cases faster to limit ongoing litigation costs and investor uncertainty.
Key developments heading into 2026:
- Bayer’s stock has been under pressure from ongoing Roundup liability concerns
- Courts continue issuing new verdicts in cases that did not settle
- Several states have enacted new rules affecting how these cases proceed locally
- New plaintiffs continue to enter the litigation pipeline
Key Takeaway: The 2026 settlement landscape is active, not closed. If you have a qualifying claim, the process is still open.
Roundup MDL Lawsuit Status: What Is Happening in Federal Court?
The Roundup MDL (multidistrict litigation), officially MDL 2741, is centralized in the Northern District of California and remains one of the most active mass tort dockets in the federal court system.
MDL consolidation means thousands of individual lawsuits are coordinated under one judge for pretrial purposes. Each plaintiff still has an individual claim, but discovery, expert witness rulings, and certain legal arguments are handled collectively. This speeds up the process and reduces costs.
The MDL has already produced three major bellwether trials. All three resulted in plaintiff victories at the jury level:
| Trial | Plaintiff | Initial Award | Outcome |
|---|---|---|---|
| Johnson v. Monsanto (2018) | Dewayne Johnson | $289 million | Reduced on appeal to $78M |
| Hardeman v. Monsanto (2019) | Edwin Hardeman | $80.3 million | Partially upheld on appeal |
| Pilliod v. Monsanto (2019) | Alva and Alberta Pilliod | $2.055 billion | Reduced significantly on appeal |
These trial results pressured Bayer into its massive settlement agreement. The MDL continues to serve as the forum for unresolved claims in 2026.
Bayer Supreme Court Roundup Preemption Ruling: What It Means for You
Bayer’s biggest legal weapon in 2026 is the preemption argument, which essentially asks courts to declare that federal EPA approval of glyphosate prevents plaintiffs from suing under state failure-to-warn laws.
This argument has reached the U.S. Supreme Court. If the Supreme Court rules in Bayer’s favor on preemption, it could severely limit or eliminate the ability of future Roundup claimants to sue under state law. That would be a massive blow to the plaintiff side.
If the Court rules against preemption, state failure-to-warn lawsuits remain fully viable. Bayer’s existing liability picture would remain as large as it already is.
The preemption ruling is the single most consequential legal development in the Roundup litigation for 2026. Anyone with a potential claim should watch this closely.
- A ruling in Bayer’s favor narrows the legal path for new claims
- A ruling against Bayer opens the door to stronger future verdicts
- Existing settled claims are not affected by this ruling
- New and pending claims could be significantly impacted
Key Takeaway: The Supreme Court preemption argument is a live threat to future claims. Filing sooner rather than later reduces your exposure to an unfavorable ruling.
Roundup Lawsuit Eligibility Requirements: The Full Checklist
To qualify for a Roundup cancer lawsuit in 2026, you need to meet a specific set of criteria that go beyond simply having used Roundup.
Attorneys screening new Roundup claims in 2026 are looking for the following:
Exposure Requirements:
- Direct personal use of Roundup or another glyphosate-based product
- Use that occurred over an extended period, typically more than one year of regular application
- Exposure that predates your cancer diagnosis
Medical Requirements:
- A confirmed diagnosis of non-Hodgkin lymphoma or a qualifying blood cancer subtype
- Diagnosis made by a licensed oncologist with supporting medical records
- The cancer must not be fully attributable to another known cause
Documentation You Will Need:
- Purchase records, receipts, or testimony establishing Roundup use
- Medical records showing your cancer diagnosis and treatment history
- Employment records if exposure was occupational
- Any photos or property records showing Roundup use at your home or workplace
The more documentation you have, the stronger your claim. Missing paperwork does not automatically disqualify you, but it does make the case harder to value.
How Long Were You Exposed to Roundup? Why Duration Matters
Exposure duration is one of the most important factors in determining both whether you qualify for the Roundup lawsuit and how much your claim could be worth.
There is no single bright-line rule that says “X years equals a qualifying claim.” But in practice, attorneys and settlement administrators look for patterns of regular, repeated use over time.
| Exposure Duration | Typical Outcome |
|---|---|
| Less than 1 year | Harder to qualify; possible in severe cancer cases |
| 1 to 5 years | Eligible in most cases with confirmed diagnosis |
| 5 to 15 years | Strong claim; higher settlement value likely |
| 15 or more years | Strongest claim category; highest potential payout |
Occupational users who sprayed Roundup daily or weekly for years have the strongest exposure claims. Homeowners who used Roundup seasonally for a decade also qualify in most cases.
If you are unsure about your exact exposure history, attorneys can help reconstruct a timeline using purchase history, employment records, and your own testimony.
Key Takeaway: More years of documented Roundup exposure directly translates to a stronger, higher-value legal claim.
Roundup Lawsuit Average Settlement Per Claimant: Real Numbers
The average Roundup lawsuit settlement per claimant falls in the range of $50,000 to $160,000, based on reported data from Bayer’s settlement programs and court filings.
That average is meaningful, but it can be misleading when applied to any individual case. Outliers on both ends exist. Some claimants settled for as little as a few thousand dollars. Others with particularly strong occupational exposure and severe cancer have settled for amounts well into the six figures.
Bayer’s 2020 settlement valued the overall program at up to $10.9 billion for approximately 100,000 claimants. That works out to a rough average of around $109,000 per claim across the full pool, before attorney fees and expenses are deducted.
Attorney fees in contingency-based cases typically range from 33% to 40% of the gross settlement. Medical liens and case expenses are subtracted separately. Your net take-home amount will be less than the gross settlement figure.
| Settlement Component | Typical Range |
|---|---|
| Gross settlement (individual) | $5,000 to $250,000+ |
| Attorney contingency fee | 33% to 40% of gross |
| Case expenses deducted | $2,000 to $10,000+ |
| Net payment to claimant | Varies by gross amount |
These numbers are based on reported patterns, not guarantees for any specific claim.
Bayer Roundup Appeal 2026: Are Verdicts Still Being Challenged?
Bayer continues to appeal jury verdicts in cases that went to trial rather than settling, and that process is still ongoing in 2026.
The appeals process has already significantly reduced several headline-grabbing verdicts. The original $289 million Johnson verdict was cut to $78 million. The Pilliod verdict of over $2 billion was reduced to a fraction of that amount on appeal. This pattern shows that even when plaintiffs win at trial, Bayer often succeeds in cutting the damages down on appeal.
For claimants who are part of the settlement program rather than individual trials, the appeals process does not directly affect their payout. Settlements are contractual agreements, not jury verdicts.
The appeals Bayer is pursuing in 2026 serve two purposes. First, they reduce Bayer’s overall payout on those specific trial cases. Second, they create legal precedent that may affect how future cases are valued and tried.
Watching which appeals courts uphold punitive damages versus stripping them out gives both plaintiffs and defendants important information about what the litigation is worth at trial.
How to File a Roundup Lawsuit in 2026: Step-by-Step Process
Filing a Roundup lawsuit in 2026 starts with a free case evaluation from a mass tort attorney who handles glyphosate claims.
You do not file directly with a court on your own in most cases. Mass tort attorneys handle the legal machinery. Your job is to gather your documentation and provide accurate information about your exposure and diagnosis.
Here is how the process works:
Step 1: Initial Case Evaluation
Contact a Roundup mass tort attorney. The consultation is free. You describe your Roundup use and cancer diagnosis. The attorney determines whether you have a qualifying claim.
Step 2: Retaining an Attorney
If your claim qualifies, you sign a contingency fee agreement. You pay nothing upfront. The attorney is paid only if your case resolves with a settlement or verdict.
Step 3: Documentation Gathering
Your attorney requests your medical records, employment history, purchase records, and any other evidence of Roundup use. This process can take several weeks.
Step 4: Claim Filing
Your attorney files your complaint in the appropriate court or submits your claim to the Bayer settlement program if you are eligible for the existing framework.
Step 5: Settlement Negotiations or Trial
Most claims settle. If Bayer’s offer is inadequate, your attorney may recommend proceeding to trial.
Roundup Lawsuit Claim Deadline 2026: Don’t Miss Your Window
The claim deadline for the Roundup lawsuit depends on your state’s statute of limitations and when you were diagnosed with cancer.
There is no single universal national deadline. Each state sets its own rules about how long you have to file a personal injury or product liability lawsuit after discovering your injury.
| State Statute of Limitations | Timeframe From Diagnosis Discovery |
|---|---|
| California | 2 years |
| Texas | 2 years |
| Florida | 4 years (changed in 2023) |
| New York | 3 years |
| Illinois | 2 years |
| Pennsylvania | 2 years |
The clock typically starts running from the date you were diagnosed or the date you reasonably should have connected your cancer to Roundup use. If you were diagnosed several years ago and have not yet filed, your window may be closing.
Do not assume someone else filed for you. Being part of a class action or MDL does not mean you automatically have a claim on file. You must take individual action.
Roundup Lawsuit Statute of Limitations: Time Is Running Out
The statute of limitations is the legal deadline to file your Roundup lawsuit, and missing it means permanently losing your right to compensation.
Most states give Roundup cancer victims between two and four years from the date of diagnosis or discovery to file their claim. In states with two-year limits, someone diagnosed in early 2024 would need to file by early 2026 to preserve their rights.
The discovery rule applies in most jurisdictions. This means the clock does not necessarily start when you were first exposed to Roundup. It starts when you knew or should have known that your cancer might be linked to Roundup.
For people who are just now learning about the lawsuit after a years-old diagnosis, this discovery rule may extend your eligibility window. But do not count on it. Courts interpret this rule narrowly in many jurisdictions.
The safest approach: treat your diagnosis date as the starting point. If significant time has passed since your diagnosis, speak to an attorney immediately rather than waiting to research further.
Key Takeaway: Statute of limitations deadlines are hard cutoffs. Missing them is permanent. Anyone with a qualifying diagnosis should consult a Roundup attorney without delay.
Roundup Lawsuit Attorney Fees Explained: What You Actually Keep
Roundup lawsuit attorneys work on a contingency fee basis, which means you pay nothing out of pocket to start your case.
If your case resolves with a settlement or trial verdict, the attorney takes a percentage of the gross amount. Standard contingency fees in mass tort cases run between 33% and 40% of your total recovery.
Beyond attorney fees, you will also see deductions for case expenses. These include costs for medical record retrieval, expert witness fees, filing fees, and administrative costs. These are typically deducted from your settlement before the attorney’s percentage is calculated, though fee structures vary by firm.
| Fee Type | Typical Amount |
|---|---|
| Attorney contingency fee | 33% to 40% of gross settlement |
| Case expense deductions | $2,000 to $15,000+ depending on complexity |
| Medical lien repayments | Varies; health insurers may have repayment rights |
| Net payment to you | Gross settlement minus all of the above |
If your case does not resolve favorably, you owe nothing. The attorney absorbs the case costs. That is the whole point of contingency representation.
Ask any attorney you speak with to put their fee structure in writing before you sign anything.
Frequently Asked Questions
Who qualifies for the Bayer Roundup lawsuit in 2026?
You qualify if you used Roundup and were later diagnosed with non-Hodgkin lymphoma or a related blood cancer.
Exposure must have been direct and repeated over time, not just a single use.
A licensed oncologist’s confirmed diagnosis is required to support your claim.
How much is the average Roundup lawsuit settlement payout?
The average Roundup lawsuit settlement payout falls between $50,000 and $160,000 per claimant.
Your specific amount depends on cancer severity, exposure duration, age, and documented medical costs.
Payments are net after attorney fees and case expenses are deducted from the gross settlement.
What cancers are linked to Roundup exposure?
Non-Hodgkin lymphoma is the primary cancer linked to Roundup and glyphosate exposure.
Specific subtypes include diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, and certain T-cell lymphomas.
Some chronic lymphocytic leukemia cases have also been included in certain claims.
Is there still time to file a Roundup lawsuit in 2026?
Yes, claims are still being accepted in 2026, but time limits vary by state and diagnosis date.
Most states allow two to four years from the date of diagnosis or discovery to file.
Anyone diagnosed with a qualifying cancer after Roundup exposure should speak to an attorney immediately to determine their deadline.
Do I need a lawyer to file a Roundup claim?
You do not legally need a lawyer, but attempting to navigate a Bayer settlement or trial without one is not advisable.
Mass tort attorneys handle all paperwork, deadlines, negotiations, and court filings.
They work on contingency, meaning no upfront cost to you, and they only get paid if your case wins or settles.
What You Should Do Right Now
The Bayer Roundup lawsuit remains one of the most consequential product liability cases in U.S. legal history. Bayer has already paid billions. More payments are being made in 2026. But the window to file a new claim is not infinite.
If you used Roundup regularly and have a cancer diagnosis, do not wait to investigate your options. The statute of limitations is the one deadline that cannot be negotiated or extended once it passes.
Speak to a Roundup mass tort attorney for a free case evaluation. Gather your medical records and any documentation of your Roundup use. Take action now while the legal process is still accessible to you.
